GERM
Amplify Treatments, Testing and Advancements ETF
GERM
GERM
Delisted
GERM was delisted on the 5th of September, 2024.
19 hedge funds and large institutions have $2.57M invested in Amplify Treatments, Testing and Advancements ETF in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
19
Holding in Top 10
–
Calls
–
Puts
–
Top Sellers
| 1 | -$1.1M | |
| 2 | -$865K | |
| 3 | -$701K | |
| 4 |
Jane Street
New York
|
-$265K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$41.6K |